Detecting hundreds of the most commonly mutated genes involved in cancer

Detecting hundreds of the most commonly mutated genes involved in cancer

Molecular Diagnostics / Cell Biology / Molecular Biology

January 23, 2017

How can you survey more than 100 oncogenes and tumor suppressor genes in your cancersamples?

The newly developed Human Comprehensive Cancer Panel allows you to enrich genes and construct libraries for NGS analysis of hundreds of genes most commonly mutated in cancer, covering oncogenes, tumor suppressor genes, genes involved in angiogenesis, apoptosis, DNA damage and repair, epigenetics, immune responses, etc. The system provides you with a complete Sample to Insight solution and a simple, streamlined workflow for routine known and novel cancer mutation detection on any NGS platform from Illumina and Ion Torrent.

 

 

New MASTR Facility supports adoption of NGS

New MASTR Facility supports adoption of NGS

Molecular Diagnostics / Cell Biology / Molecular B...

Multiplicom is pleased to announce the new MASTR Facility to enable the implementation of massively parallel sequencing capabilities in clinical genetics and pathology laboratories.

September 15, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us